Woodline Partners’s Benitec Biopharma BNTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$291K Buy
+29,118
New +$356K ﹤0.01% 1018
2026
Q1
– Sell
-100,704
Closed -$1.36M – 1043
2025
Q4
$1.36M Buy
+100,704
New +$1.39M 0.01% 812

Other funds holding BNTC

Woodline Partners's BNTC Position: Q3 2026 in Review

Woodline Partners opened a new position in Benitec Biopharma (BNTC) in Q3 2026: 29,118 shares worth $291K. The stake represents ﹤0.01% of the portfolio and ranks #1018 among its holdings. This is a return to the name: Woodline Partners previously reported a position in BNTC as recently as Q4 2025.

Woodline Partners first reported a position in BNTC in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.36M in Q4 2025. 91 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.

  • Woodline Partners held 29,118 shares of Benitec Biopharma worth $291K as of Q3 2026.
  • Benitec Biopharma was a new Woodline Partners position in Q3 2026.
  • Benitec Biopharma made up ﹤0.01% of Woodline Partners's portfolio in Q3 2026, its #1018 holding.
  • Woodline Partners first reported a position in Benitec Biopharma in Q4 2025 and has held it in 2 quarters since.
  • Woodline Partners's Benitec Biopharma position peaked at $1.36M in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.

Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.